Alliance for Building Better Medicine Secures $15.97M EDA Grant
RICHMOND, Va., July 20, 2026 Virginia’s Advanced Pharmaceutical Manufacturing (APM) Tech Hub has secured a $15.97 million investment from...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
RICHMOND, Va., July 20, 2026 Virginia’s Advanced Pharmaceutical Manufacturing (APM) Tech Hub has secured a $15.97 million investment from...
LAKE OSWEGO, Ore., July 20, 2026 BIOTRONIK Neuro has unveiled Embrace One® Proactive Intelligence, a proprietary artificial intelligence (AI)...
